Investing

Larimar Therapeutics stock price target lowered to $7 at Jones Trading

In other recent news, Larimar Therapeutics has reported notable developments concerning its ongoing study of nomlabofusp for Friedreich’s ataxia. The company announced positive data, highlighting that ...
Hosted on MSN

Larimar Therapeutics Announces Positive Study Results

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Larimar Therapeutics ( (LRMR)) has issued ...
Benzinga.com

Larimar Therapeutics Stock Falls After Patients Report Allergic Reaction In Pivotal Study

Larimar Therapeutics Inc. (NASDAQ: LRMR) is trading lower on Monday after the company released data from the ongoing long-term open-label (OL) study evaluating daily subcutaneous 25 mg and 50 mg ...
Business Insider

Larimar Therapeutics Announces Positive Data from Ongoing Long-term Open Label Study and Updates to Nomlabofusp Program for Friedreich’s Ataxia

In 4 completed studies and the ongoing OL study, 65 participants received at least 1 dose of nomlabofusp, including 39 in the OL study, with 14 on treatment for at least 6 months and 8 for over 1 year ...
The Business Journals

Larimar Therapeutics' stock price tumbles on mixed study results for lead drug candidate

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Larimar Therapeutics reports ...
Business Insider

Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia

BALA CYNWYD, Pa., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...
Oregonian

‘Like nothing I’ve seen’: Discovering the otherworldly geology of Oregon’s Owyhee Canyonlands

Oregon’s Owyhee Canyonlands might be defined by its remoteness, but what truly sets this eastern Oregon wilderness apart is its otherworldly beauty and surprising diversity of recreational ...
Investing

Larimar Therapeutics’ SWOT analysis: nomlabofusp’s potential reshapes FA stock outlook

Larimar Therapeutics, Inc. (NASDAQ:LRMR) is poised at a critical juncture as it prepares to unveil crucial data for its flagship drug candidate, nomlabofusp, a potential treatment for Friedreich’s ...
Hosted on MSN

Larimar Therapeutics Reports Q2 2025 Financial Results

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Larimar Therapeutics ( (LRMR)) has issued ...
Yahoo Finance

Larimar: Q2 Earnings Snapshot

BALA CYNWYD, Pa. (AP) — BALA CYNWYD, Pa. (AP) — Larimar Therapeutics, Inc. (LRMR) on Thursday reported a loss of $26.2 million in its second quarter. The Bala Cynwyd, Pennsylvania-based company said ...
Scientific American

The Geology of Texas’ ‘Flash Flood Alley’ Explained

The following essay is reprinted with permission from The Conversation, an online publication covering the latest research. Texas Hill Country is known for its landscapes, where shallow rivers wind ...